TIAA CREF Investment Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $5.53M | Sell |
116,506
-4,525
| -4% | -$215K | ﹤0.01% | 1375 |
|
|
2018
Q4 | $4.37M | Sell |
121,031
-2,683
| -2% | -$96.9K | ﹤0.01% | 1465 |
|
|
2018
Q3 | $7.62M | Buy |
123,714
+39,014
| +46% | +$2.4M | 0.01% | 1286 |
|
|
2018
Q2 | $5.72M | Sell |
84,700
-5,692
| -6% | -$384K | ﹤0.01% | 1502 |
|
|
2018
Q1 | $4.9M | Buy |
90,392
+996
| +1% | +$54K | ﹤0.01% | 1565 |
|
|
2017
Q4 | $5.34M | Sell |
89,396
-11,001
| -11% | -$657K | ﹤0.01% | 1563 |
|
|
2017
Q3 | $4.88M | Sell |
100,397
-23,841
| -19% | -$1.16M | ﹤0.01% | 1641 |
|
|
2017
Q2 | $6.53M | Buy |
124,238
+9,781
| +9% | +$514K | ﹤0.01% | 1414 |
|
|
2017
Q1 | $5.19M | Sell |
114,457
-6,289
| -5% | -$285K | ﹤0.01% | 1575 |
|
|
2016
Q4 | $4.57M | Buy |
120,746
+7,531
| +7% | +$285K | ﹤0.01% | 1661 |
|
|
2016
Q3 | $4.27K | Buy |
113,215
+10,759
| +11% | +$406 | ﹤0.01% | 1708 |
|
|
2016
Q2 | $1.8M | Buy |
102,456
+747
| +0.7% | +$13.1K | ﹤0.01% | 2183 |
|
|
2016
Q1 | $1.24M | Sell |
101,709
-2,190
| -2% | -$26.6K | ﹤0.01% | 2356 |
|
|
2015
Q4 | $2.53M | Sell |
103,899
-6,619
| -6% | -$161K | ﹤0.01% | 2011 |
|
|
2015
Q3 | $1.96M | Buy |
110,518
+21,577
| +24% | +$383K | ﹤0.01% | 2153 |
|
|
2015
Q2 | $1.57M | Buy |
88,941
+48,959
| +122% | +$864K | ﹤0.01% | 2451 |
|
|
2015
Q1 | $1.25M | Sell |
39,982
-1,779
| -4% | -$55.8K | ﹤0.01% | 2492 |
|
|
2014
Q4 | $1.22M | Sell |
41,761
-2,708
| -6% | -$79K | ﹤0.01% | 2542 |
|
|
2014
Q3 | $920K | Buy |
44,469
+6,700
| +18% | +$139K | ﹤0.01% | 2677 |
|
|
2014
Q2 | $936K | Buy |
37,769
+11,800
| +45% | +$292K | ﹤0.01% | 2756 |
|
|
2014
Q1 | $550K | Buy |
25,969
+5,900
| +29% | +$125K | ﹤0.01% | 2912 |
|
|
2013
Q4 | $360K | Buy |
+20,069
| New | +$360K | ﹤0.01% | 3027 |
|